Hims & Hers' recurring revenue, strong margins, and rapid growth make it a standout investment. Read an analysis of HIMS ...

Hims & Hers ($HIMS) stock rose 2.6% on Monday after the U.S. Food and Drug Administration (FDA) released a “green list” of ...

Hims & Hers Health said on Wednesday it is launching a new category in men's health, offering access to personalized ...

GoodRx will offer the GLP-1s for $499 a month, the lowest-ever out-of-pocket cost for the weight-loss medications.

In Novo Nordisk’s legal fight against dozens of U.S. pharmacies and companies selling cheaper copies of its weight-loss drug ...

Shares of Hims Hers Health Inc (NYSE:HIMS) jumped 8.2% Wednesday after a key legal development eased market concerns about potential litigation from major pharmaceutical companies. A federal judge’s ...

Hims & Hers is an American telehealth company incorporated in Delaware and headquartered in San Francisco, California. On April 29, 2025, Hims & Hers announced a long-term collaboration with Novo ...

If you are a long-term stockholder in Hims & Hers between April 29, 2025 and June 23, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion ...